Liu YQ - Search Results

1

Wang ZB, Liu YQ, Cui YF. Wang ZB, et al. Among authors: liu yq. Cell Biol Int. 2005 Jul;29(7):489-96. doi: 10.1016/j.cellbi.2005.04.001. Cell Biol Int. 2005. PMID: 15939633 Review.

2

Bcl-xL overexpression restricts gamma-radiation-induced apoptosis.

Wang ZB, Zhang Y, Liu YQ, Guo Y, Xu H, Dong B, Cui YF. Wang ZB, et al. Among authors: liu yq. Cell Biol Int. 2006 Jan;30(1):15-20. doi: 10.1016/j.cellbi.2005.08.006. Epub 2005 Oct 25. Cell Biol Int. 2006. PMID: 16253528

3

Reactive oxygen species, but not mitochondrial membrane potential, is associated with radiation-induced apoptosis of AHH-1 human lymphoblastoid cells.

Wang ZB, Liu YQ, Zhang Y, Li Y, An XX, Xu H, Guo Y, Jin W, Jiang ZJ, Cui YF. Wang ZB, et al. Among authors: liu yq. Cell Biol Int. 2007 Nov;31(11):1353-8. doi: 10.1016/j.cellbi.2007.05.009. Epub 2007 May 21. Cell Biol Int. 2007. PMID: 17587607

4

Increase of CD4(+)CD25(+) T cells in Smad3(-/-) mice.

Wang ZB, Cui YF, Liu YQ, Jin W, Xu H, Jiang ZJ, Lu YX, Zhang Y, Liu XL, Dong B. Wang ZB, et al. Among authors: liu xl, liu yq. World J Gastroenterol. 2006 Apr 21;12(15):2455-8. doi: 10.3748/wjg.v12.i15.2455. World J Gastroenterol. 2006. PMID: 16688844 Free PMC article.

5

Role of fibrosarcoma-induced CD11b⁺ myeloid cells and tumor necrosis factor-α in B cell responses.

Wang Z, Liu Y, Peng L, Till B, Liao Y, Yuan S, Yan X, Chen L, Fu Q, Qin Z. Wang Z, et al. Oncogene. 2022 Mar;41(10):1434-1444. doi: 10.1038/s41388-022-02187-z. Epub 2022 Jan 15. Oncogene. 2022. PMID: 35034094

6

Low-dose anlotinib confers improved survival in combination with immune checkpoint inhibitor in advanced non-small cell lung cancer patients.

Yuan S, Peng L, Liu Y, Till BG, Yan X, Zhang J, Zhu L, Wang H, Zhang S, Li H, Gao Q, Wang Z. Yuan S, et al. Cancer Immunol Immunother. 2023 Feb;72(2):437-448. doi: 10.1007/s00262-022-03259-5. Epub 2022 Aug 5. Cancer Immunol Immunother. 2023. PMID: 35931835 Free PMC article.

7

MDSC-decreasing chemotherapy increases the efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma and pancreatic cancer.

Wang Z, Liu Y, Zhang Y, Shang Y, Gao Q. Wang Z, et al. Oncotarget. 2016 Jan 26;7(4):4760-9. doi: 10.18632/oncotarget.6734. Oncotarget. 2016. PMID: 26716894 Free PMC article.

8

Association of myeloid-derived suppressor cells and efficacy of cytokine-induced killer cell immunotherapy in metastatic renal cell carcinoma patients.

Wang Z, Zhang Y, Liu Y, Wang L, Zhao L, Yang T, He C, Song Y, Gao Q. Wang Z, et al. J Immunother. 2014 Jan;37(1):43-50. doi: 10.1097/CJI.0000000000000005. J Immunother. 2014. PMID: 24316555

9

Pretreatment Peripheral B Cells Are Associated With Tumor Response to Anti-PD-1-Based Immunotherapy.

Yuan S, Liu Y, Till B, Song Y, Wang Z. Yuan S, et al. Front Immunol. 2020 Oct 9;11:563653. doi: 10.3389/fimmu.2020.563653. eCollection 2020. Front Immunol. 2020. PMID: 33162976 Free PMC article.

10

Autologous cytokine-induced killer cell transfusion increases overall survival in advanced pancreatic cancer.

Wang Z, Liu Y, Li R, Shang Y, Zhang Y, Zhao L, Li W, Yang Y, Zhang X, Yang T, Nie C, Han F, Liu Y, Luo S, Gao Q, Song Y. Wang Z, et al. J Hematol Oncol. 2016 Feb 3;9:6. doi: 10.1186/s13045-016-0237-6. J Hematol Oncol. 2016. PMID: 26842696 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

1,715 results

Search Page